232 related articles for article (PubMed ID: 9433928)
1. Differential expression of matrix metalloproteinases and their tissue inhibitors in leiomyomata: a mechanism for gonadotrophin releasing hormone agonist-induced tumour regression.
Dou Q; Tarnuzzer RW; Williams RS; Schultz GS; Chegini N
Mol Hum Reprod; 1997 Nov; 3(11):1005-14. PubMed ID: 9433928
[TBL] [Abstract][Full Text] [Related]
2. Suppression of transforming growth factor-beta (TGF beta) and TGF beta receptor messenger ribonucleic acid and protein expression in leiomyomata in women receiving gonadotropin-releasing hormone agonist therapy.
Dou Q; Zhao Y; Tarnuzzer RW; Rong H; Williams RS; Schultz GS; Chegini N
J Clin Endocrinol Metab; 1996 Sep; 81(9):3222-30. PubMed ID: 8784073
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D3 inhibits expression and activities of matrix metalloproteinase-2 and -9 in human uterine fibroid cells.
Halder SK; Osteen KG; Al-Hendy A
Hum Reprod; 2013 Sep; 28(9):2407-16. PubMed ID: 23814095
[TBL] [Abstract][Full Text] [Related]
4. Progesterone receptor modulator CDB-2914 induces extracellular matrix metalloproteinase inducer in cultured human uterine leiomyoma cells.
Xu Q; Ohara N; Liu J; Amano M; Sitruk-Ware R; Yoshida S; Maruo T
Mol Hum Reprod; 2008 Mar; 14(3):181-91. PubMed ID: 18216291
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical study of the proliferation index, oestrogen receptors and progesterone receptors A and B in leiomyomata and normal myometrium during the menstrual cycle and under gonadotrophin-releasing hormone agonist therapy.
Nisolle M; Gillerot S; Casanas-Roux F; Squifflet J; Berliere M; Donnez J
Hum Reprod; 1999 Nov; 14(11):2844-50. PubMed ID: 10548634
[TBL] [Abstract][Full Text] [Related]
6. Fibromodulin is expressed in leiomyoma and myometrium and regulated by gonadotropin-releasing hormone analogue therapy and TGF-beta through Smad and MAPK-mediated signalling.
Levens E; Luo X; Ding L; Williams RS; Chegini N
Mol Hum Reprod; 2005 Jul; 11(7):489-94. PubMed ID: 16123076
[TBL] [Abstract][Full Text] [Related]
7. Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis.
Sutinen M; Kainulainen T; Hurskainen T; Vesterlund E; Alexander JP; Overall CM; Sorsa T; Salo T
Br J Cancer; 1998 Jun; 77(12):2239-45. PubMed ID: 9649139
[TBL] [Abstract][Full Text] [Related]
8. Expression of matrix metalloproteinase-2, -9, -14, and tissue inhibitors of metalloproteinase-1, -2, -3 in the endometrium and placenta of rhesus monkey (Macaca mulatta) during early pregnancy.
Wang H; Li Q; Shao L; Zhu C
Biol Reprod; 2001 Jul; 65(1):31-40. PubMed ID: 11420220
[TBL] [Abstract][Full Text] [Related]
9. Activity of matrix metalloproteinase-2 and -9 and contents of their tissue inhibitors in uterine leiomyoma and corresponding myometrium.
Bogusiewicz M; Stryjecka-Zimmer M; Postawski K; Jakimiuk AJ; Rechberger T
Gynecol Endocrinol; 2007 Sep; 23(9):541-6. PubMed ID: 17943549
[TBL] [Abstract][Full Text] [Related]
10. Expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in inflammation-induced corneal neovascularization.
Ma DH; Chen JK; Kim WS; Hao YX; Wu HC; Tsai RJ; Hwang DG; Zhang F
Ophthalmic Res; 2001; 33(6):353-62. PubMed ID: 11721189
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of stromelysin 3 mRNA in leiomyomas (uterine fibroids) compared with myometrium.
Palmer SS; Haynes-Johnson D; Diehl T; Nowak RA
J Soc Gynecol Investig; 1998; 5(4):203-9. PubMed ID: 9699179
[TBL] [Abstract][Full Text] [Related]
12. Regulation of matrix metalloproteinases (MMPs) and their tissue inhibitors in human myometrial smooth muscle cells by TGF-beta1.
Ma C; Chegini N
Mol Hum Reprod; 1999 Oct; 5(10):950-4. PubMed ID: 10508223
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of mac25 mRNA in uterine leiomyomata compared with adjacent myometrium.
Kim JG; Kim MH; Kim IS; Moon SY; Kang SB; Lee HP; Lee JY
Am J Reprod Immunol; 2000 Jan; 43(1):53-7. PubMed ID: 10698042
[TBL] [Abstract][Full Text] [Related]
14. Leiomyoma and myometrial gene expression profiles and their responses to gonadotropin-releasing hormone analog therapy.
Luo X; Ding L; Xu J; Williams RS; Chegini N
Endocrinology; 2005 Mar; 146(3):1074-96. PubMed ID: 15604208
[TBL] [Abstract][Full Text] [Related]
15. Gonadotropin-releasing hormone (GnRH) and GnRH receptor gene expression in human myometrium and leiomyomata and the direct action of GnRH analogs on myometrial smooth muscle cells and interaction with ovarian steroids in vitro.
Chegini N; Rong H; Dou Q; Kipersztok S; Williams RS
J Clin Endocrinol Metab; 1996 Sep; 81(9):3215-21. PubMed ID: 8784072
[TBL] [Abstract][Full Text] [Related]
16. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the mouse uterus during the peri-implantation period.
Das SK; Yano S; Wang J; Edwards DR; Nagase H; Dey SK
Dev Genet; 1997; 21(1):44-54. PubMed ID: 9291579
[TBL] [Abstract][Full Text] [Related]
17. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ
Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
[TBL] [Abstract][Full Text] [Related]
18. Quantitative estimation of matrix metalloproteinases 2 and 7 (MMP-2, MMP-7) and tissue inhibitors of matrix metalloproteinases 1 and 2 (TIMP-1, TIMP-2) in colorectal carcinoma tissue samples.
Pesta M; Holubec L; Topolcan O; Cerna M; Rupert K; Holubec LS; Treska V; Kormunda S; Elgrova L; Finek J; Cerny R
Anticancer Res; 2005; 25(5):3387-91. PubMed ID: 16101153
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases by cytokines and growth factors in bovine endometrial stromal cells and trophoblast cell line BT-1 in vitro.
Hirata M; Sato T; Tsumagari M; Shimada A; Nakano H; Hashizume K; Ito A
Biol Reprod; 2003 Apr; 68(4):1276-81. PubMed ID: 12606436
[TBL] [Abstract][Full Text] [Related]
20. Expression of matrix metalloproteinases MMP-2, MMP-9 and their tissue inhibitors TIMP-1, -2, and -3 in benign and malignant tumours of the salivary gland.
Nagel H; Laskawi R; Wahlers A; Hemmerlein B
Histopathology; 2004 Mar; 44(3):222-31. PubMed ID: 14987225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
